Seascape Capital Management acquired a new position in AbbVie Inc (NYSE:ABBV) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 25,753 shares of the company’s stock, valued at approximately $2,280,000. AbbVie comprises about 1.6% of Seascape Capital Management’s investment portfolio, […]